DNA mismatch repair and cancer

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Li, Guo Min ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cancer; HNPCC; Microsatellite instability; Mismatch repair; Review

Indexed keywords

BACTERIAL PROTEIN; CISPLATIN; METHOTREXATE; METHYLNITRONITROSOGUANIDINE; PROCARBAZINE; PROTEIN MUTL; PROTEIN MUTS; TEMOZOLOMIDE; TIOGUANINE; UNCLASSIFIED DRUG;

APOPTOSIS; COLON POLYPOSIS; COLORECTAL CANCER; DNA DAMAGE; DNA RECOMBINATION; DNA REPLICATION; DRUG MEGADOSE; GENE MUTATION; GENETIC CODE; GENOME; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; ANIMAL; BASE MISPAIRING; DNA REPAIR; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; BASE PAIR MISMATCH; DNA REPAIR; HUMANS; NEOPLASMS;

EID: 0345357346     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1121     Document Type: Review

References (282)

1. Loeb, L. A.: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075-3079 (1991)
2. Loeb, L. A., K. R. Loeb, & J. P. Anderson: Multiple mutations and cancer. Proc Natl Acad Sci USA 100, 776-81 (2003)
3. Tiraby, J.-G. & M. S. Fox: Marker discrimination in transformation and mutation of pneumococcus. Proc Natl Acad Sci USA 70, 3541-3545 (1973)
4. Nevers, P. & H. Spatz: Escherichia coli mutants uvrD uvrE deficient in gene conversion of lambda heteroduplexes. Mol Gen Genet 139, 233-243 (1975)
5. Modrich, P.: Mechanisms and biological effects of mismatch repair. Ann Rev Genet 25, 229-253 (1991)
6. Kolodner, R.: Biochemistry and genetics of eukaryotic mismatch repair. Genes & Dev 10, 1433-1442 (1996)
7. Kolodner, R. D. & G. T. Marsischky: Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9, 89-96 (1999)
8. Hsieh, P.: Molecular mechanisms of DNA mismatch repair. Mutat Res 486, 71-87 (2001)
9. Yang, W.: Structure and function of mismatch repair proteins. Mutat Res 460, 245-56 (2000)
10. Evans, E. & E. Alani: Roles for mismatch repair factors in regulating genetic recombination. Mol Cell Biol 20, 7839-44 (2000)
11. Harfe, B. D. & S. Jinks-Robertson: DNA mismatch repair and genetic instability. Annu Rev Genet 34, 359-399 (2000)
12. Sixma, T. K.: DNA mismatch repair: MutS structures bound to mismatches. Curr Opin Struct Biol 11, 47-52 (2001)
13. Fishel, R. & R. D. Kolodner: Identification of mismatch repair genes and their role in the development of cancer. Curr Opin. Genet Dev 5, 382-395 (1995)
14. Modrich, P. & R. Lahue: Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65, 101-33 (1996)
15. Umar, A. & T. A. Kunkel: DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 238, 297-307 (1996)
16. Crose, G.: Mismatch repair systems in Saccharomyces cerevisiae. In: DNA damage and repair, Volume 1, DNA repair in prokaryotes and lower eukaryotes. Eds: Nickoloff JA, Hoekstra MF, Humana Press, Totowa, NJ 1, 411-448 (1997)
17. Jiricny, J.: Replication errors: cha(lle)nging the genome. Embo J 17, 6427-36 (1998)
18. Buermeyer, A. B., S. M. Deschenes, S. M. Baker, & R. M. Liskay: Mammalian DNA mismatch repair. Annu Rev Genet 33, 533-64 (1999)
19. Lahue, R. S., K. G. Au, & P. Modrich: DNA mismatch correction in a defined system. Science 245, 160-164 (1989)
20. Cooper, D. L., R. S. Lahue, & P. Modrich: Methyl- directed mismatch repair is bidirectional. J Biol Chem 268, 11823-9 (1993)
21. Burdett, V., C. Baitinger, M. Viswanathan, S. T. Lovett, & P. Modrich: In vivo requirement for RecJ, ExoVII, Exol, and ExoX in methyl-directed mismatch repair. Proc Natl Acad Sci U S A 98, 6765-70 (2001)
22. Su, S.-S. & P. Modrich: Escherichia coli mutS-encoded protein binds to mismatched DNA base pairs. Proc Natl Acad Sci U S A 83, 5057-5061 (1986)
23. Parker, B. O. & M. G. Marinus: Repair of DNA heteroduplexes containing small heterologous sequences in Escherichia coli. Proc Natl Acad Sci U S A 89, 1730-1734 (1992)
24. Haber, L. T. & G. C. Walker: Altering the conserved nucleotide binding motif in the Salmonella typhimurium MutS mismatch repair protein affects both its ATPase and mismatch binding activities. EMBO J 10, 2707-2715 (1991)
25. Wu, T. H. & M. G. Marinus: Dominant negative mutator mutations in the mutS gene of Escherichia coli. J Bacteriol 176, 5393-400 (1994)
26. Junop, M. S., G. Obmolova, K. Rausch, P. Hsieh, & W. Yang: Composite active site of an ABC ATPase: MutS uses ATP to verify mismatch recognition and authorize DNA repair. Mol Cell 7, 1-12 (2001)
27. Obmolova, G., C. Ban, P. Hsieh, & W. Yang: Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature 407, 703-10 (2000)
28. Lamers, M. H., A. Perrakis, J. H. Enzlin, H. H. Winterwerp, N. de Wind, & T. K. Sixma: The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch. Nature 407, 711-7 (2000)
29. Allen, D. J., A. Makhov, M. Grilley, J. Taylor, R. Thresher, P. Modrich, & J. D. Griffith: MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J 16, 4467-4476 (1997)
30. Biswas, I., C. Ban, K. G. Fleming, J. Qin, J. W. Lary, D. A. Yphantis, W. Yang, & P. Hsieh: Oligomerization of a MutS mismatch repair protein from Thermus aquaticus. J Biol Chem 274, 23673-8 (1999)
31. Yang, W., M. S. Junop, C. Ban, G. Obmolova, & P. Gsieh: DNA mismatch repair: from structure to mechanism. Cold Spring Harbor Symp. Quant. Biol 65, (2000)
32. Grilley, M., K. M. Welsh, S.-S. Su, & P. Modrich: Isolation and characterization of the Escherichia coli mutL gene product. J Biol Chem 264, 1000-1004 (1989)
33. Au, K. G., K. Welsh, & P. Modrich: Initiation of methyl-directed mismatch repair. J Biol Chem 267, 12142-8 (1992)
34. Ban, C. & W. Yang: Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis. Cell 95, 541-52 (1998)
35. Hall, M. C. & S. W. Matson: The Escherichia coli MutL protein physically interacts with MutH and stimulates the MutH-associated endonuclease activity. J Biol Chem 274, 1306-12 (1999)
36. Dao, V. & P. Modrich: Mismatch-, MutS-, MutL-, and helicase II-dependent unwinding from the single-strand break of an incised heteroduplex. J Biol Chem 273, 9202-7 (1998)
37. Yamaguchi, M., V. Dao, & P. Modrich: MutS and MutL activate DNA helicase II in a mismatch-dependent manner. J Biol Chem 273, 9197-201 (1998)
38. Hall, M. C., J. R. Jordan, & S. W. Matson: Evidence for a physical interaction between the Escherichia coli methyl- directed mismatch repair proteins MutL and UvrD. Embo J 17, 1535-41 (1998)
39. Mechanic, L. E., B. A. Frankel, & S. W. Matson: Escherichia coli MutL loads DNA helicase II onto DNA. J Biol Chem 275, 38337-46 (2000)
40. Sancar, A. & J. E. Hearst: Molecular matchmakers. Science 259, 1415-1420 (1993)
41. Ban, C., M. Junop, & W. Yang: Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell 97, 85-97 (1999)
42. Aronshtam, A. & M. G. Marinus: Dominant negative mutator mutations in the mutL gene of Escherichia coli. Nucleic Acids Res 24, 2498-504 (1996)
43. Spampinato, C. & P. Modrich: The MutL ATPase is required for mismatch repair. J Biol Chem 275, 9863-9 (2000)
44. Ban, C. & W. Yang: Structural basis for MutH activation in E.coli mismatch repair and relationship of MutH to restriction endonucleases. Embo J 17, 1526-34 (1998)
45. Welsh, K. M., A.-L. Lu, S. Clark, & P. Modrich: Isolation and characterization of the Escherichia coli mutH gene product. J Biol Chem 262, 15624-15629 (1987)
46. Fishel, R.: Mismatch repair, molecular switches, and signal transduction. Genes & Dev 12, 2096-101 (1998)
47. Gradia, S., D. Subramanian, T. Wilson, S. Acharya, A. Makhov, J. Griffith, & R. Fishel: hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol Cell 3, 255-61 (1999)
48. Grilley, M., J. Griffith, & P. Modrich: Bidirectional excision in methyl-directed mismatch repair. J Biol Chem 268, 11830-7 (1993)
49. Fang, W., J. Y. Wu, & M. J. Su: Methyl-directed repair of mismatched small heterologous sequences in cell extracts from Escherichia coli. J Biol Chem 272, 22714-20 (1997)
50. Holmes, J., S. Clark, & P. Modrich: Strand-specific mismatch correction in nuclear extracts of human and Drosophila melanogaster cell lines. Proc Natl Acad Sci U S A 87, 5837-5841 (1990)
51. Thomas, D. C., J. D. Roberts, & T. A. Kunkel: Heteroduplex repair in extracts of human HeLa cells. J Biol Chem 266, 3744-3751 (1991)
52. + tumor cells. Cell 75, 1227-36 (1993)
53. Umar, A., J. C. Boyer, D. C. Thomas, D. C. Nguyen, J. I. Risinger, J. Boyd, Y. Ionov, M. Perucho, & T. A. Kunkel: Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 269, 14367-70 (1994)
54. Drummond, J. T., G. M. Li, M. J. Longley, & P. Modrich: Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268, 1909-12 (1995)
55. McCulloch, S. D., L. Gu, & G. M. Li: Bi-directional Processing of DNA Loops by Mismatch Repair-dependent and -independent Pathways in Human Cells. J Biol Chem 278, 3891-6 (2003)
56. Genschel, J., S. J. Littman, J. T. Drummond, & P. Modrich: Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα. J Biol Chem 273, 19895-19901 (1998)
57. Fang, W. H. & P. Modrich: Human strand-specific mismatch repair occurs by a bidirectional mechanism similar to that of the bacterial reaction. J Biol Chem 268, 11838-44 (1993)
58. Tishkoff, D. X., N. S. Amin, C. S. Viars, K. C. Arden, & R. D. Kolodner: Identification of a human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an exonuclease implicated in mismatch repair and recombination. Cancer Res 58, 5027-31 (1998)
59. Amin, N. S., M. N. Nguyen, S. Oh, & R. D. Kolodner: exol-Dependent mutator mutations: model system for studying functional interactions in mismatch repair. Mol Cell Biol 21, 5142-55 (2001)
60. Sokolsky, T. & E. Alani: EXO1 and MSH6 are high- copy suppressors of conditional mutations in the MSH2 mismatch repair gene of Saccharomyces cerevisiae.PG - 589-99. Genetics 155, (2000)
61. Schmutte, C., R. C. Marinescu, M. M. Sadoff, S. Guerrette, J. Overhauser, & R. Fishel: Human exonuclease I interacts with the mismatch repair protein hMSH2. Cancer Res 58, 4537-42 (1998)
62. Tran, P. T., J. A. Simon, & R. M. Liskay: Interactions of Exo1p with components of MutLα in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 98, 9760-5 (2001)
63. Genschel, J., L. R. Bazemore, & P. Modrich: Human exonuclease I is required for 5′ and 3′ mismatch repair. J Biol Chem 277, 13302-11 (2002)
64. Lin, Y. L., M. K. Shivji, C. Chen, R. Kolodner, R. D. Wood, & A. Dutta: The evolutionarily conserved zinc finger motif in the largest subunit of human replication protein A is required for DNA replication and mismatch repair but not for nucleotide excision repair. J Biol Chem 273, 1453-61 (1998)
65. Ramilo, C., L. Gu, S. Guo, X. Zhang, S. M. Patrick, J. J. Turchi, & G. M. Li: Partial Reconstitution of Human DNA Mismatch Repair In vitro: Characterization of the Role of Human Replication Protein A. Mol Cell Biol 22, 2037-2046 (2002)
66. Umar, A., A. B. Buermeyer, J. Simon, D. C. Thomas, A. B. Clark, R. M. Liskay, & T. A. Kunkel: Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87, 65-73 (1996)
67. Gu, L., Y. Hong, S. McCulloch, H. Watanabe, & G.-M. Li: ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair. Nucleic Acids Res 26, 1173-1178 (1998)
68. Kleczkowska, H. E., G. Marra, T. Lettieri, & J. Jiricny: hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci. Genes & Dev 15, 724-36 (2001)
69. Bowers, J., P. T. Tran, A. Joshi, R. M. Liskay, & E. Alani: MSH-MLH complexes formed at a DNA mismatch are disrupted by the PCNA sliding clamp. J Mol Biol 306, 957-68 (2001)
70. Clark, A. B., F. Valle, K. Drotschmann, R. K. Gary, & T. A. Kunkel: Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes. J Biol Chem 275, 36498-501 (2000)
71. Flores-Rozas, H., D. Clark, & R. D. Kolodner: Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex. Nat Genet 26, 375-8 (2000)
72. Longley, M. J., A. J. Pierce, & P. Modrich: DNA polymerase δ is required for human mismatch repair in vitro. J Biol Chem 272, 10917-21 (1997)
73. Schmidt, K. H., K. L. Derry, & R. D. Kolodner: Saccharomyces cerevisiae RRM3, a 5′ to 3′ DNA Helicase, Physically Interacts with Proliferating Cell Nuclear Antigen. J Biol Chem 277, 45331-7 (2002)
74. Palombo, F., I. Iaccarino, E. Nakajima, M. Ikejima, T. Shimada, & J. Jiricny: hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr Biol 6, 1181-4 (1996)
75. Alani, E., T. Sokolsky, B. Studamire, J. J. Miret, & R. S. Lahue: Genetic and biochemical analysis of Msh2p-Msh6p: role of ATP hydrolysis and Msh2p-Msh6p subunit interactions in mismatch base pair recognition. Mol Cell Biol 17, 2436-47 (1997)
76. Gradia, S., S. Acharya, & R. Fishel: The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch. Cell 91, 995-1005 (1997)
77. Iaccarino, I., G. Marra, F. Palombo, & J. Jiricny: hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSα. Embo J 17, 2677-86 (1998)
78. Blackwell, L. J., K. P. Bjornson, & P. Modrich: DNA- dependent activation of the hMutSα ATPase. J Biol Chem 273, 32049-54 (1998)
79. Blackwell, L. J., D. Martik, K. P. Bjornson, E. S. Bjornson, & P. Modrich: Nucleotide-promoted release of hMutSα from heteroduplex DNA is consistent with an ATP-dependent translocation mechanism. J Biol Chem 273, 32055-62 (1998)
80. Wilson, T., S. Guerrette, & R. Fishel: Dissociation of mismatch recognition and ATPase activity by hMSH2- hMSH3. J Biol Chem 274, 21659-64 (1999)
81. Bronner, C. E., S. Baker, P. T. Morrison, G. Warren, L. G. Smith, M. K. Lescoe, M. Kane, C. Earabino, J. Lipford, A. Lindblom, P. Tannergard, R. J. Bollag, A. R. Godwin, D. C. Ward, M. Nordenskjold, R. Fishel, R. Kolodner, & R. M. Liskay: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258-61 (1994)
82. Nicolaides, N. C., N. Papadopoulos, B. Liu, Y.-F. Wei, K. C. Carter, S. M. Ruben, C. A. Rosen, W. A. Haseltine, R. D. Fleischmann, C. M. Fraser, M. D. Adams, J. C. Venter, M. G. Dunlop, S. R. Hamilton, G. M. Petersen, A. de la Chapelle, B. Vogelstein, & K. W. Kinzler: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371, 75-80 (1994)
83. Papadopoulos, N., N. C. Nicolaides, Y.-F. Wei, S. M. Ruben, K. C. Carter, C. A. Rosen, W. A. Haseltine, R. D. Fleischmann, C. M. Fraser, M. D. Adams, J. C. Venter, S. R. Hamilton, G. M. Peterson, P. Watson, H. T. Lynch, P. Peltomäki, J.-P. Mecklin, A. de la Chapelle, K. W. Kinzler, & B. Vogelstein: Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625-1629 (1994)
84. Lipkin, S. M., V. Wang, R. Jacoby, S. Banerjee-Basu, A. D. Baxevanis, H. T. Lynch, R. M. Elliott, & F. S. Collins: MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet 24, 27-35 (2000)
85. Li, G. M. & P. Modrich: Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci U S A 92, 1950-4 (1995)
86. Raschle, M., G. Marra, M. Nystrom-Lahti, P. Schar, & J. Jiricny: Identification of hMutLβ, a Heterodimer of hMLH1 and hPMS1. J Biol Chem 274, 32368-32375 (1999)
87. Leung, W. K., J. J. Kim, L. Wu, J. L. Sepulveda, & A. R. Sepulveda: Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J Biol Chem 275, 15728-32. (2000)
88. Flores-Rozas, H. & R. D. Kolodner: The Saccharomyces cerevisiae MLH3 gene functions in MSH3- dependent suppression of frameshift mutations. Proc Natl Acad Sci U S A 95, 12404-9 (1998)
89. Lipkin, S. M., P. B. Moens, V. Wang, M. Lenzi, D. Shanmugarajah, A. Gilgeous, J. Thomas, J. Cheng, J. W. Touchman, E. D. Green, P. Schwartzberg, F. S. Collins, & P. E. Cohen: Meiotic arrest and aneuploidy in MLH3- deficient mice. Nat Genet 31, 385-90 (2002)
90. Hall, M. C., P. V. Shcherbakova, & T. A. Kunkel: Differential ATP binding and intrinsic ATP hydrolysis by amino-terminal domains of the yeast Mlh1 and Pms1 proteins. J Biol Chem 277, 3673-9 (2002)
91. Hall, M. C., H. Wang, D. A. Erie, & T. A. Kunkel: High affinity cooperative DNA binding by the yeast Mlh1- Pms1 heterodimer. J Mol Biol 312, 637-47 (2001)
92. Raschle, M., P. Dufner, G. Marra, & J. Jiricny: Mutations within the hMLH1 and hPMS2 subunits of the human MutLα mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSα. J Biol Chem (2002)
93. Tomer, G., A. B. Buermeyer, M. M. Nguyen, & R. M. Liskay: Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair. J Biol Chem 277, 21801-9 (2002)
94. Tran, P. T. & R. M. Liskay: Functional studies on the candidate ATPase domains of Saccharomyces cerevisiae MutLα. Mol Cell Biol 20, 6390-8 (2000)
95. Guarne, A., M. S. Junop, & W. Yang: Structure and function of the N-terminal 40 kDa fragment of human PMS2: a monomeric GHL ATPase. Embo J 20, 5521-31 (2001)
96. Prolla, T. A., Q. Pang, E. Alani, R. D. Kolodner, & R. M. Liskay: MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science 265, 1091-3 (1994)
97. Matunis, M. J.: On the road to repair: PCNA encounters SUMO and ubiquitin modifications. Mol Cell 10, 441-2 (2002)
98. Paunesku, T., S. Mittal, M. Protic, J. Oryhon, S. V. Korolev, A. Joachimiak, & G. E. Woloschak: Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 77, 1007-21 (2001)
99. Lau, P. J. & R. D. Kolodner: Transfer of the MSH2-MSH6 complex from proliferating cell nuclear antigen to mispaired bases in DNA. J Biol. Chem (2003)
100. Tishkoff, D. X., A. L. Boerger, P. Bertrand, N. Filosi, G. M. Gaida, M. F. Kane, & R. D. Kolodner: Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2. Proc Natl Acad Sci U S A 94, 7487-92 (1997)
101. Wei, K., A. B. Clark, E. Wong, M. F. Kane, D. J. Mazur, T. Parris, N. K. Kolas, R. Russell, H. Hou, Jr., B. Kneitz, G. Yang, T. A. Kunkel, R. D. Kolodner, P. E. Cohen, & W. Edelmann: Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes & Dev 17, 603-14 (2003)
102. Lynch, H. T., T. C. Smyrk, P. Watson, S. J. Lanspa, J. F. Lynch, P. M. Lynch, R. J. Cavalieri, & C. R. Boland: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104, 1535-1549 (1993)
103. Lynch, H. T., G. S. Schuelke, W. J. Kimberling, W. A. Albano, J. F. Lynch, K. A. Biscone, M. L. Lipkin, E. E. Deschner, Y. B. Mikol, A. A. Sandberg, R. C. Elston, J. E. Bailey-Wilson, & B. S. Danes: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer 56, 939-51 (1985)
104. Dunlop, M. G.: Screening for large bowel neoplasms in individuals with a family history of colorectal cancer [see comments]. Br J Surg 79, 488-94 (1992)
105. Lynch, H. T., S. Lanspa, T. Smyrk, B. Boman, P. Watson, & J. Lynch: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet Cytogenet 53, 143-60 (1991)
106. Watson, P. & H. T. Lynch: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71, 677-85 (1993)
107. Warthin, A. S.: Heredity with reference to carcinoma. Arch Intern Med 12, 546-555 (1913)
108. Peltomäki, P., L. A. Aaltonen, P. Sistonen, L. Pylkkänen, J.-P. Mecklin, H. Järvinen, J. S. Green, J. R. Jass, J. L. Weber, F. S. Leach, G. M. Petersen, S. R. Hamilton, A. de la Chapelle, & B. Vogelstein: Genetic mapping of a locus predisposing to human colorectal cancer. Science 260, 810-2 (1993)
109. Aaltonen, L. A., P. Peltomäki, F. S. Leach, P. Sistonen, L. Pylkkänen, J.-P. Mecklin, H. Järvinen, S. M. Powell, J. Jen, S. R. Hamilton, G. M. Petersen, K. W. Kinzler, B. Vogelstein, & A. de la Chapelle: Clues to the pathogenesis of familial colorectal cancer. Science 260, 812-6 (1993)
110. Ionov, Y., M. A. Peinado, S. Malkhosyan, D. Shibata, & M. Perucho: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558-61 (1993)
111. Thibodeau, S. N., G. Bren, & D. Schaid: Microsatellite instability in cancer of the proximal colon. Science 260, 816-819 (1993)
112. Kat, A., W. G. Thilly, W. H. Fang, M. J. Longley, G. M. Li, & P. Modrich: An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci U S A 90, 6424-8 (1993)
113. Levinson, G. & G. A. Gutman: High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucleic Acids Res 15, 5323-5338 (1987)
114. Levinson, G. & G. A. Gutman: Slipped-strand mispairing: A major mechanism for DNA sequence evolution. Mol Biol Evol 4, 203-221 (1987)
115. Strand, M., T. A. Prolla, R. M. Liskay, & T. D. Petes: Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365, 274-6 (1993)
116. Reenan, R. A. & R. D. Kolodner: Isolation and characterization of two Saccharomyces cerevisiae genes encoding homologs of the bacterial HexA and MutS mismatch repair proteins. Genetics 132, 963-73 (1992)
117. Fishel, R., M. K. Lescoe, M. R. Rao, N. G. Copeland, N. A. Jenkins, J. Garber, M. Kane, & R. Kolodner: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027-38 (1993)
118. Leach, F. S., N. C. Nicolaides, N. Papadopoulos, B. Liu, J. Jen, R. Parsons, P. Peltomaki, P. Sistonen, L. A. Aaltonen, L. M. Nystrom, & a. l. et: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215-25 (1993)
119. Lindblom, A., P. Tannergard, B. Werelius, & M. Nordenskjold: Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 5, 279-282 (1993)
120. Liu, B., R. E. Parsons, S. R. Hamilton, G. M. Peterson, H. T. Lynch, P. Watson, S. Markowitz, J. K. V. Willson, J. Green, A. de la Chapelle, K. W. Kinzler, & B. Vogelstein: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54, 4590-4 (1994)
121. Lynch, H. T., T. Drouhard, S. Lanspa, T. Smyrk, P. Lynch, J. Lynch, B. Vogelstein, M. Nystrom-Lahti, P. Sistonen, P. Peltomaki, & A. de la Chapelle: Mutation of an mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 86, 1417-9 (1994)
122. Mary, J. L., T. Bishop, R. Kolodner, J. R. Lipford, M. Kane, W. Weber, J. Torhorst, H. Muller, M. Spycher, & R. J. Scott: Mutational analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development. Hum Mol Genet 3, 2067-9 (1994)
123. Hemminki, A., P. Peltomaki, J. P. Mecklin, H. Jarvinen, R. Salovaara, L. M. Nystrom, de, la, Chapelle, A, & L. A. Aaltonen: Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet 8, 405-10 (1994)
124. Wijnen, J., H. Vasen, P. M. Khan, F. H. Menko, H. van der Klift, C. van Leeuwen, M. van den Broek, I. van Leeuwen-Cornelisse, F. Nagengast, A. Meijers-Heijboer, D. Lindhout, G. Griffioen, A. Catt, J. Kleibeuker, L. Varesco, L. Bertario, M. L. Bisgaard, J. Mohr, & R. Fodde: Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56, 1060-6 (1995)
125. Liu, B., R. Parsons, N. Papadopoulos, N. C. Nicolaides, H. T. Lynch, P. Watson, J. R. Jass, M. Dunlop, A. Wyllie, P. Peltomaki, de, la, Chapelle, A, S. R. Hamilton, B. Vogelstein, & K. W. Kinzler: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2, 169-74 (1996)
126. Han, H. J., M. Maruyama, S. Baba, J. G. Park, & Y. Nakamura: Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC). Hum Mol Genet 4, 237-42 (1995)
127. Kolodner, R. D., N. R. Hall, J. Lipford, M. F. Kane, M. R. Rao, P. Morrison, L. Wirth, P. J. Finan, J. Burn, P. Chapman, C. Earabino, E. Merchant, & D. T. Bishop: Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 24, 516-26 (1994)
128. Kolodner, R. D., N. R. Hall, J. Lipford, M. F. Kane, P. T. Morrison, P. J. Finan, J. Burn, P. Chapman, C. Earabino, E. Merchant, & D. T. Bishop: Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res 55, 242-8 (1995)
129. Luce, M. C., G. Marra, D. P. Chauhan, L. Laghi, J. M. Carethers, S. P. Cherian, M. Hawn, C. G. Binnie, M. L. Kam, M. C. Cayouette, M. Koi, & C. R. Boland: In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 109, 1368-74 (1995)
130. Tannergard, P., J. R. Lipford, R. Kolodner, J. E. Frodin, M. Nordenskjold, & A. Lindblom: Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res 55, 6092-6 (1995)
131. Maliaka, Y. K., A. P. Chudina, N. F. Belev, P. Alday, N. P. Bochkov, & J. M. Buerstedde: CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. Hum Genet 97, 251-5 (1996)
132. Wijnen, J., P. M. Khan, H. Vasen, F. Menko, van, der, Klift, H, van, den, Broek, M, L. van, I. Cornelisse, F. Nagengast, H. E. Meijers, D. Lindhout, G. Griffioen, A. Cats, J. Kleibeuker, L. Varesco, L. Bertario, M. L. Bisgaard, J. Mohr, R. Kolodner, & R. Fodde: Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet 58, 300-7 (1996)
133. Liu, T., S. Wahlberg, C. Rubio, E. Holmberg, H. Gronberg, & A. Lindblom: DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer. Clin Genet 53, 131-5 (1998)
134. Miyaki, M., M. Konishi, K. Tanaka, Y. R. Kikuchi, M. Muraoka, M. Yasuno, T. Igari, M. Koike, M. Chiba, & T. Mori: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17, 271-2 (1997)
135. Kolodner, R. D., J. D. Tytell, J. L. Schmeits, M. F. Kane, R. D. Gupta, J. Weger, S. Wahlberg, E. A. Fox, D. Peel, A. Ziogas, J. E. Garber, S. Syngal, H. Anton-Culver, & F. P. Li: Germ-line msh6 mutations in colorectal cancer families. Cancer Res 59, 5068-74 (1999)
136. Loukola, A., S. Vilkki, J. Singh, V. Launonen, & L. A. Aaltonen: Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer. Am J Pathol 157, 347-52 (2000)
137. Lipkin, S. M., V. Wang, D. L. Stoler, G. R. Anderson, I. Kirsch, D. Hadley, H. T. Lynch, & F. S. Collins: Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Hum Mutat 17, 389-96 (2001)
138. Wu, Y., M. J. Berends, R. H. Sijmons, R. G. Mensink, E. Verlind, K. A. Kooi, T. van der Sluis, C. Kempinga, A. G. van dDer Zee, H. Hollema, C. H. Buys, J. H. Kleibeuker, & R. M. Hofstra: A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 29, 137-8 (2001)
139. Wu, Y., M. J. Berends, J. G. Post, R. G. Mensink, E. Verlind, T. Van Der Sluis, C. Kempinga, R. H. Sijmons, A. G. van der Zee, H. Hollema, J. H. Kleibeuker, C. H. Buys, & R. M. Hofstra: Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology 120, 1580-7 (2001)
140. Jagmohan-Changur, S., T. Poikonen, S. Vilkki, V. Launonen, F. Wikman, T. F. Orntoft, P. Moller, H. Vasen, C. Tops, R. D. Kolodner, J. P. Mecklin, H. Jarvinen, S. Bevan, R. S. Houlston, L. A. Aaltonen, R. Fodde, J. Wijnen, & A. Karhu: EXO1 Variants Occur Commonly in Normal Population: Evidence against a Role in Hereditary Nonpolyposis Colorectal Cancer. Cancer Res 63, 154-8 (2003)
141. Sun, X., L. Zheng, & B. Shen: Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome. Cancer Res 62, 6026-30 (2002)
142. Parsons, R., G. M. Li, M. Longley, P. Modrich, B. Liu, T. Berk, S. R. Hamilton, K. W. Kinzler, & B. Vogelstein: Mismatch repair deficiency in phenotypically normal human cells. Science 268, 738-40 (1995)
143. Risinger, J. I., A. Umar, J. C. Barrett, & T. A. Kunkel: A hPMS2 mutant cell line is defective in strand-specific mismatch repair. J Biol Chem 270, 18183-18186 (1995)
144. Boyer, J. C., A. Umar, J. I. Risinger, J. R. Lipford, M. Kane, S. Yin, J. C. Barrett, R. D. Kolodner, & T. A. Kunkel: Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 55, 6063-70 (1995)
145. Risinger, J., A. Umar, J. Boyd, A. Berchuck, T. A. Kunkel, & J. C. Barrett: Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nature Genet 14, 102-105 (1996)
146. Eshleman, J. R., S. D. Markowitz, P. S. Donover, E. Z. Lang, J. D. Lutterbaugh, G.-M. Li, M. Longley, P. Modrich, M. L. Veigl, & W. D. Sedwick: Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability. Oncogene 12, 1425-1432 (1996)
147. Veigl, M. L., L. Kasturi, J. Olechnowicz, A. H. Ma, J. D. Lutterbaugh, S. Periyasamy, G. M. Li, J. Drummond, P. L. Modrich, W. D. Sedwick, & S. D. Markowitz: Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A 95, 8698-702 (1998)
148. Eshleman, J. R., P. S. Donover, S. J. Littman, S. E. Swinler, G. M. Li, J. D. Lutterbaugh, J. K. Willson, P. Modrich, W. D. Sedwick, S. D. Markowitz, & M. L. Veigl: Increased transversions in a novel mutator colon cancer cell line. Oncogene 16, 1125-30 (1998)
149. Koi, M., A. Umar, D. P. Chauhan, S. P. Cherian, J. M. Carethers, T. A. Kunkel, & C. R. Boland: Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N- nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 54, 4308-12 (1994)
150. Umar, A., M. Koi, J. I. Risinger, W. E. Glaab, K. R. Tindall, R. D. Kolodner, C. R. Boland, J. C. Barrett, & T. A. Kunkel: Correction of hypermutability, N-methyl-N′- nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res 57, 3949-55 (1997)
151. Tindall, K. R., W. E. Glaab, A. Umar, J. I. Risinger, M. Koi, J. C. Barrett, & T. A. Kunkel: Complementation of mismatch repair gene defects by chromosome transfer. Mutat Res 402, 15-22 (1998)
152. Risinger, J. I., A. Umar, W. E. Glaab, K. R. Tindall, T. A. Kunkel, & J. C. Barrett: Single gene complementation of the hPMS2 defect in HEC-1-A endometrial carcinoma cells. Cancer Res 58, 2978-81 (1998)
153. Buermeyer, A. B., C. Wilson-Van Patten, S. M. Baker, & R. M. Liskay: The human MLH1 cDNA complements DNA mismatch repair defects in Mlh1- deficient mouse embryonic fibroblasts. Cancer Res 59, 538-41 (1999)
154. Umar, A., J. I. Risinger, W. E. Glaab, K. R. Tindall, J. C. Barrett, & T. A. Kunkel: Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics 148, 1637-46 (1998)
155. Lettieri, T., G. Marra, G. Aquilina, M. Bignami, N. E. Crompton, F. Palombo, & J. Jiricny: Effect of hMSH6 cDNA expression on the phenotype of mismatch repair- deficient colon cancer cell line HCT15. Carcinogenesis 20, 373-82 (1999)
156. Baker, S. M., C. E. Bronner, L. Zhang, A. W. Plug, M. Robatzek, G. Warren, E. A. Elliott, J. Yu, T. Ashley, N. Arnheim, R. A. Flavell, & R. M. Liskay: Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82, 309-19 (1995)
157. de Wind, N., M. Dekker, A. Berns, M. Radman, & H. te Riele: Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82, 321-30 (1995)
158. Reitmair, A. H., R. Schmits, A. Ewel, B. Bapat, M. Redston, A. Mitri, P. Waterhouse, H. W. Mittrucker, A. Wakeham, B. Liu, A. Thomason, H. Griesser, S. Gallinger, W. G. Ballhausen, R. Fishel, & T. W. Mak: MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nature Genet 11, 64-70 (1995)
159. Baker, S. M., A. W. Plug, T. A. Prolla, C. E. Bronner, A. C. Harris, X. Yao, D. M. Christie, C. Monell, N. Arnheim, A. Bradley, T. Ashley, & R. M. Liskay: Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet 13, 336-42 (1996)
160. Edelmann, W., P. E. Cohen, M. Kane, K. Lau, B. Morrow, S. Bennett, A. Umar, T. Kunkel, G. Cattoretti, R. Chaganti, J. W. Pollard, R. D. Kolodner, & R. Kucherlapati: Meiotic pachytene arrest in MLH1-deficient mice. Cell 85, 1125-34 (1996)
161. Edelmann, W., K. Yang, A. Umar, J. Heyer, K. Lau, K. Fan, W. Liedtke, P. E. Cohen, M. F. Kane, J. R. Lipford, N. Yu, G. F. Crouse, J. W. Pollard, T. Kunkel, M. Lipkin, R. Kolodner, & R. Kucherlapati: Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell 91, 467-77 (1997)
162. Prolla, T. A., S. M. Baker, A. C. Harris, J. L. Tsao, X. Yao, C. E. Bronner, B. Zheng, M. Gordon, J. Reneker, N. Arnheim, D. Shibata, A. Bradley, & R. M. Liskay: Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 18, 276-9 (1998)
163. de Wind, N., M. Dekker, N. Claij, L. Jansen, Y. van Klink, M. Radman, G. Riggins, M. van der Valk, K. van't Wout, & H. te Riele: HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nat Genet 23, 359-62 (1999)
164. Edelmann, W., A. Umar, K. Yang, J. Heyer, M. Kucherlapati, M. Lia, B. Kneitz, E. Avdievich, K. Fan, E. Wong, G. Crouse, T. Kunkel, M. Lipkin, R. D. Kolodner, & R. Kucherlapati: The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res 60, 803-7 (2000)
165. Prolla, T. A.: DNA mismatch repair and cancer. Curr Opin Cell Biol 10, 311-6 (1998)
166. Wei, K., R. Kucherlapati, & W. Edelmann: Mouse models for human DNA mismatch-repair gene defects. Trends Mol Med 8, 346-53 (2002)
167. Yao, X., A. B. Buermeyer, L. Narayanan, D. Tran, S. M. Baker, T. A. Prolla, P. M. Glazer, R. M. Liskay, & N. Arnheim: Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc Natl Acad Sci U S A 96, 6850-5 (1999)
168. Liu, B., N. C. Nicolaides, S. Markowitz, J. K. V. Willson, R. E. Parsons, J. Jen, A. de la Chapelle, S. R. Hamilton, K. Kinzler, & B. Vogelstein: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 9, 48-55 (1995)
169. Thibodeau, S. N., A. J. French, P. C. Roche, J. M. Cunningham, D. J. Tester, N. M. Lindor, G. Moslein, S. M. Baker, R. M. Liskay, L. J. Burgart, R. Honchel, & K. C. Halling: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56, 4836-40 (1996)
170. Borresen, A. L., R. A. Lothe, G. I. Meling, S. Lystad, P. Morrison, J. Lipford, M. F. Kane, T. O. Rognum, & R. D. Kolodner: Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 4, 2065-72 (1995)
171. Kane, M. F., M. Loda, G. M. Gaida, J. Lipman, R. Mishra, H. Goldman, J. M. Jessup, & R. Kolodner: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57, 808-11 (1997)
172. Larsen, C. J.: Methylation is a frequent mechanism of inactivation of the hMLH1 gene copies in sporadic colonic cancer. Bull Cancer 85, 741-2 (1998)
173. Herman, J. G., A. Umar, K. Polyak, J. R. Graff, N. Ahuja, J. P. Issa, S. Markowitz, J. K. Willson, S. R. Hamilton, K. W. Kinzler, M. F. Kane, R. D. Kolodner, B. Vogelstein, T. A. Kunkel, & S. B. Baylin: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95, 6870-5 (1998)
174. Cunningham, J. M., E. R. Christensen, D. J. Tester, C. Y. Kim, P. C. Roche, L. J. Burgart, & S. N. Thibodeau: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58, 3455-60 (1998)
175. Leung, S. Y., S. T. Yuen, L. P. Chung, K. M. Chu, A. S. Chan, & J. C. Ho: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59, 159-64 (1999)
176. Benachenhou, N., S. Guiral, I. Gorska-Flipot, R. Michalski, D. Labuda, & D. Sinnett: Allelic losses and DNA methylation at DNA mismatch repair loci in sporadic colorectal cancer. Carcinogenesis 19, 1925-9 (1998)
177. Boland, C. R., S. N. Thibodeau, S. R. Hamilton, D. Sidransky, J. R. Eshleman, R. W. Burt, S. J. Meltzer, M. A. Rodriguez-Bigas, R. Fodde, G. N. Ranzani, & S. Srivastava: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58, 5248-57 (1998)
178. Thibodeau, S. N., A. J. French, J. M. Cunningham, D. Tester, L. J. Burgart, P. C. Roche, S. K. McDonnell, D. J. Schaid, C. W. Vockley, V. V. Michels, G. H. Farr, Jr., & M. J. O'Connell: Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58, 1713-8 (1998)
179. Gazzoli, I., M. Loda, J. Garber, S. Syngal, & R. D. Kolodner: A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62, 3925-8 (2002)
180. Eshleman, J. R. & S. D. Markowitz: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7, 83-9 (1995)
181. Arzimanoglou, II, F. Gilbert, & H. R. Barber: Microsatellite instability in human solid tumors. Cancer 82, 1808-20 (1998)
182. Li, G. M., S. McCulloch, & L. Gu: DNA mismatch repair in tumor suppression. In: Tumor suppressor genes in human cancer. Ed: Fisher DE, The Humana Press Inc., Totowa, NJ, 197-229 (2000)
183. Kodera, T., T. Kohno, S. Takakura, K. Morishita, H. Hamaguchi, Y. Hayashi, T. Sasaki, & J. Yokota: Microsatellite instability in lymphoid leukemia and lymphoma cell lines but not in myeloid leukemia cell lines. Genes Chromosomes Cancer 26, 267-9 (1999)
184. Mao, L., D. J. Lee, M. S. Tockman, Y. S. Erozan, F. Askin, & D. Sidransky: Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 91, 9871-5 (1994)
185. Homfray, T. F., S. E. Cottrell, M. Ilyas, A. Rowan, I. C. Talbot, W. F. Bodmer, & I. P. Tomlinson: Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum Mutat 11, 114-20 (1998)
186. Benachenhou, N., S. Guiral, I. Gorska-Flipot, D. Labuda, & D. Sinnett: High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer. Int J Cancer 77, 173-80 (1998)
187. Swisher, E. M., D. G. Mutch, T. J. Herzog, J. S. Rader, L. D. Kowalski, A. Elbendary, & P. J. Goodfellow: Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair. J Soc Gynecol Investig 5, 210-6 (1998)
188. Inokuchi, K., M. Ikejima, A. Watanabe, E. Nakajima, H. Orimo, T. Nomura, & T. Shimada: Loss of expression of the human MSH3 gene in hematological malignancies. Biochem Biophys Res Commun 214, 171-9 (1995)
189. Yamamoto, H., H. Sawai, T. K. Weber, B. M. Rodriguez, & M. Perucho: Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res 58, 997-1003 (1998)
190. Yamamoto, H., H. Sawai, & M. Perucho: Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 57, 4420-6 (1997)
191. Malkhosyan, S., N. Rampino, H. Yamamoto, & M. Perucho: Frameshift mutator mutations. Nature 382, 499-500 (1996)
192. Yin, J., D. Kong, S. Wang, T. T. Zou, R. F. Souza, K. N. Smolinski, P. M. Lynch, S. R. Hamilton, H. Sugimura, S. M. Powell, J. Young, J. M. Abraham, & S. J. Meltzer. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum Mutat 10, 474-8 (1997)
193. Velasco, A., S. M. Hewitt, P. S. Albert, M. Hossein, H. Rosenberg, C. Martinez, A. I. Sagalowsky, J. D. McConnell, W. Marston, & F. S. Leach: Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence. Cancer 94, 690-9 (2002)
194. Murata, H., N. H. Khattar, Y. Kang, L. Gu, & G. M. Li: Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene 21, 5696-703 (2002)
195. Esteller, M., R. Levine, S. B. Baylin, L. H. Ellenson, & J. G. Herman: MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17, 2413-7 (1998)
196. Gurin, C. C., M. G. Federici, L. Kang, & J. Boyd: Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 59, 462-6 (1999)
197. Thykjaer, T., M. Christensen, A. B. Clark, L. R. Hansen, T. A. Kunkel, & T. F. Orntoft: Functional analysis of the mismatch repair system in bladder cancer. Br J Cancer 85, 568-75 (2001)
198. Gu, L., J. Wu, B. B. Zhu, & G. M. Li: Deficiency of a novel mismatch repair activity in a bladder tumor cell line. Nucleic Acids Res 30, 2758-63 (2002)
199. Kinzler, K. W. & B. Vogelstein: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761, 763 (1997)
200. Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, & J. K. V. Wilson: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-8 (1995)
201. Yagi, O. K., Y. Akiyama, Y. Ohkura, S. Ban, M. Endo, K. Saitoh, & Y. Yuasa: Analyses of the APC and TGF-β type II receptor genes, and microsatellite instability in mucosal colorectal carcinomas. Jpn J Cancer Res 88, 718-24 (1997)
202. Samowitz, W. S. & M. L. Slattery: Transforming growth factor-β receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. Am J Pathol 151, 33-5 (1997)
203. Percesepe, A., P. Kristo, L. A. Aaltonen, M. Ponz de Leon, A. de la Chapelle, & P. Peltomaki: Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability. Oncogene 17, 157-63 (1998)
204. Parsons, R., L. L. Myeroff, B. Liu, J. K. Willson, S. D. Markowitz, K. W. Kinzler, & B. Vogelstein: Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 55, 5548-50 (1995)
205. Wang, J., L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J. K. Willson, & M. G. Brattain: Demonstration that mutation of the type II transforming growth factor □ receptor inactivates its tumor suppressor activity in replication error- positive colon carcinoma cells. J Biol Chem 270, 22044-9 (1995)
206. Grady, W. M., A. Rajput, L. Myeroff, D. F. Liu, K. Kwon, J. Willis, & S. Markowitz: Mutation of the type II transforming growth factor-□ receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 58, 3101-4 (1998)
207. Myeroff, L. L., R. Parsons, S. J. Kim, L. Hedrick, K. R. Cho, K. Orth, M. Mathis, K. W. Kinzler, J. Lutterbaugh, K. Park, Y. Bang, H. Y. Lee, J. Park, H. T. Lynch, A. B. Roberts, B. Vogelstein, & S. D. Markowitz: A transforming growth factor □ receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55, 5545-7 (1995)
208. Akiyama, Y., R. Iwanaga, T. Ishikawa, K. Sakamoto, N. Nishi, Z. Nihei, T. Iwama, K. Saitoh, & Y. Yuasa: Mutations of the transforming growth factor-□ type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability. Cancer 78, 2478-84 (1996)
209. Renault, B., D. Calistri, G. Buonsanti, O. Nanni, D. Amadori, & G. N. Ranzani: Microsatellite instability and mutations of p53 and TGF-β RII genes in gastric cancer. Hum Genet 98, 601-7 (1996)
210. Souza, R. F., J. Yin, K. N. Smolinski, T. T. Zou, S. Wang, Y. Q. Shi, M. G. Rhyu, J. Cottrell, J. M. Abraham, K. Biden, L. Simms, B. Leggett, G. S. Bova, T. Frank, S. M. Powell, H. Sugimura, J. Young, N. Harpaz, K. Shimizu, N. Matsubara, & S. J. Meltzer: Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res 57, 2350-3 (1997)
211. Ohue, M., N. Tomita, T. Monden, Y. Miyoshi, T. Ohnishi, H. Izawa, Y. Kawabata, M. Sasaki, M. Sekimoto, I. Nishisho, H. Shiozaki, & M. Monden: Mutations of the transforming growth factor □ type II receptor gene and microsatellite instability in gastric cancer. Int J Cancer 68, 203-6 (1996)
212. Izumoto, S., N. Arita, T. Ohnishi, S. Hiraga, T. Taki, N. Tomita, M. Ohue, & T. Hayakawa: Microsatellite instability and mutated type II transforming growth factor- □ receptor gene in gliomas. Cancer Lett 112, 251-6 (1997)
213. Chu, T. Y., J. S. Lai, C. Y. Shen, H. S. Liu, & C. F. Chao: Frequent aberration of the transforming growth factor-□ receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix. Int J Cancer 80, 506-10 (1999)
214. Wang, D., H. Song, J. A. Evans, J. C. Lang, D. E. Schuller, & C. M. Weghorst: Mutation and downregulation of the transforming growth factor □ type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 18, 2285-90 (1997)
215. Souza, R. F., J. Lei, J. Yin, R. Appel, T. T. Zou, X. Zhou, S. Wang, M. G. Rhyu, K. Cymes, O. Chan, W. S. Park, M. J. Krasna, B. D. Greenwald, J. Cottrell, J. M. Abraham, L. Simms, B. Leggett, J. Young, N. Harpaz, & S. J. Meltzer: A transforming growth factor □ 1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology 112, 40-5 (1997)
216. Togo, G., N. Toda, F. Kanai, N. Kato, Y. Shiratori, K. Kishi, F. Imazeki, M. Makuuchi, & M. Omata: A transforming growth factor □ type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res 56, 5620-3 (1996)
217. Rampino, N., H. Yamamoto, Y. Ionov, Y. Li, H. Sawai, J. C. Reed, & M. Perucho: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967-969 (1997)
218. Brimmell, M., R. Mendiola, J. Mangion, & G. Packham: BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16, 1803-12 (1998)
219. Catasus, L., X. Matias-Guiu, P. Machin, J. Munoz, & J. Prat: BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability. Lab Invest 78, 1439-44 (1998)
220. Molenaar, J. J., B. Gerard, C. Chambon-Pautas, H. Cave, M. Duval, E. Vilmer, & B. Grandchamp: Microsatellite instability and frameshift mutations in BAX and transforming growth factor-β RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines. Blood 92, 230-3 (1998)
221. Oliveira, C., R. Seruca, M. Seixas, & M. Sobrinho- Simoes: The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFβ RII, IGFII R, and BAX genes. Am J Pathol 153, 1211-9 (1998)
222. Sakakibara, T., T. Nakamura, M. Yamamoto, & M. Matsuo: Microsatellite instability in Japanese hereditary non-polyposis colorectal cancer does not induce mutation of a simple repeat sequence of the bax gene. Cancer Lett 124, 193-7 (1998)
223. Sakao, Y., M. Noro, S. Sekine, M. Nozue, S. Hirohashi, T. Itoh, & M. Noguchi: Microsatellite instability and frameshift mutations in the Bax gene in hereditary nonpolyposis colorectal carcinoma. Jpn J Cancer Res 89, 1020-7 (1998)
224. Leung, S. Y., S. T. Yuen, L. P. Chung, K. M. Chu, M. P. Wong, F. J. Branicki, & J. C. Ho: Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor □ receptor and BAX in gastric carcinomas in Hong Kong Chinese. Br J Cancer 79, 582-8 (1999)
225. Yoshinaga, K., H. Sasano, T. Furukawa, H. Yamakawa, M. Yuki, S. Sato, A. Yajima, & A. Horii: The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. Jpn J Cancer Res 89, 985-90 (1998)
226. Souza, R. F., R. Appel, J. Yin, S. Wang, K. N. Smolinski, J. M. Abraham, T. T. Zou, Y. Q. Shi, J. Lei, J. Cottrell, K. Cymes, K. Biden, L. Simms, B. Leggett, P. M. Lynch, M. Frazier, S. M. Powell, N. Harpaz, H. Sugimura, J. Young, & S. J. Meltzer: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 14, 255-7 (1996)
227. Ouyang, H., H. O. Shiwaku, H. Hagiwara, K. Miura, T. Abe, Y. Kato, H. Ohtani, K. Shiiba, R. F. Souza, S. J. Meltzer, & A. Horii: The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 57, 1851-4 (1997)
228. Yoshitaka, T., N. Matsubara, M. Ikeda, M. Tanino, H. Hanafusa, N. Tanaka, & K. Shimizu: Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. Biochem Biophys Res Commun 227, 553-7 (1996)
229. Huang, J., N. Papadopoulos, A. J. McKinley, S. M. Farrington, L. J. Curtis, A. H. Wyllie, S. Zheng, J. K. Willson, S. D. Markowitz, P. Morin, K. W. Kinzler, B. Vogelstein, & M. G. Dunlop: APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A 93, 9049-54 (1996)
230. Laken, S. J., G. M. Petersen, S. B. Gruber, C. Oddoux, H. Ostrer, F. M. Giardiello, S. R. Hamilton, H. Hampel, A. Markowitz, D. Klimstra, S. Jhanwar, S. Winawer, K. Offit, M. C. Luce, K. W. Kinzler, & B. Vogelstein: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17, 79-83 (1997)
231. Reitmair, A. H., J. C. Cai, M. Bjerknes, M. Redston, H. Cheng, M. T. Pind, K. Hay, A. Mitri, B. V. Bapat, T. W. Mak, & S. Gallinger: MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res 56, 2922-6 (1996)
232. Kong, D., A. Suzuki, T. T. Zou, A. Sakurada, L. W. Kemp, S. Wakatsuki, T. Yokoyama, H. Yamakawa, T. Furukawa, M. Sato, N. Ohuchi, S. Sato, J. Yin, S. Wang, J. M. Abraham, R. F. Souza, K. N. Smolinski, S. J. Meltzer, & A. Horii: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17, 143-4 (1997)
233. Levine, R. L., C. B. Cargile, M. S. Blazes, B. van Rees, R. J. Kurman, & L. H. Ellenson: PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58, 3254-8 (1998)
234. Tashiro, H., M. S. Blazes, R. Wu, K. R. Cho, S. Bose, S. I. Wang, J. Li, R. Parsons, & L. H. Ellenson: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57, 3935-40 (1997)
235. Ohmiya, N., S. Matsumoto, H. Yamamoto, S. Baranovskaya, S. R. Malkhosyan, & M. Perucho: Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 272, 301-13 (2001)
236. Giannini, G., E. Ristori, F. Cerignoli, C. Rinaldi, M. Zani, A. Viel, L. Ottini, M. Crescenzi, S. Martinotti, M. Bignami, L. Frati, I. Screpanti, & A. Gulino: Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 3, 248-54 (2002)
237. Yamada, T., T. Koyama, S. Ohwada, K. Tago, I. Sakamoto, S. Yoshimura, K. Hamada, I. Takeyoshi, & Y. Morishita: Frameshift mutations in the MBD4/MED1 gene in primary gastric cancer with high-frequency microsatellite instability. Cancer Lett 181, 115-20 (2002)
238. Li, G.-M.: The role of mismatch repair in DNA damage- induced apoptosis. Oncol Res 11, 393-400 (1999)
239. Fram, R. J., P. S. Cusick, J. M. Wilson, & M. G. Marinus: Mismatch repair of cis-diamminedichloroplatinum(II)- induced DNA damage. Mol Pharmacol 28, 51-55 (1985)
240. Jones, M. & R. Wagner: N-Methyl-N′-nitro-N-nitrosoguanidine sensitivity of E. coli mutants deficient in DNA methylation and mismatch repair. Mol Gen Genet 184, 562-563 (1981)
241. Karran, P. & M. Marinus: Mismatch correction at O6-methylguanine residues in E. coli DNA. Nature 296, 868-869 (1982)
242. Goldmacher, V. S., R. A. Cuzick, & W. G. Thilly: Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro- nitrosoguanidine. J Biol Chem 261, 12462-12471 (1986)
243. Papadopoulos, N., N. C. Nicolaides, B. Liu, R. E. Parsons, F. Palombo, A. D'Arrigo, S. Markowitz, J. K. V. Willson, K. Kinzler, J. Jiricny, & B. Vogelstein: Mutations in GTBP in genetically unstable cells. Science 268, 1914-1917 (1995)
244. Hawn, M. T., A. Umar, J. M. Carethers, G. Marra, T. A. Kunkel, C. R. Boland, & M. Koi: Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res 55, 3721-5 (1995)
245. Branch, P., G. Aquilina, M. Bignami, & P. Karran: Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362, 652-4 (1993)
246. Aquilina, G., P. Hess, P. Branch, C. MacGeoch, I. Casciano, P. Karran, & M. Bignami: A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc Natl Acad Sci U S A 91, 8905-9 (1994)
247. Aquilina, G., P. Hess, S. Fiumicino, S. Ceccotti, & M. Bignami: A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage. Cancer Res 55, 2569-75 (1995)
248. Levati, L., G. Marra, T. Lettieri, S. D'Atri, P. Vernole, L. Tentori, P. M. Lacal, E. Pagani, E. Bonmassar, J. Jiricny, & G. Graziani: Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer 23, 159-66 (1998)
249. Fink, D., S. Aebi, & S. B. Howell: The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4, 1-6 (1998)
250. D'Atri, S., L. Tentori, P. M. Lacal, G. Graziani, E. Pagani, E. Benincasa, G. Zambruno, E. Bonmassar, & J. Jiricny: Involvement of the mismatch repair system in temozolomide- induced apoptosis. Mol Pharmacol 54, 334-41 (1998)
251. Friedman, H. S., S. P. Johnson, Q. Dong, S. C. Schold, B. K. Rasheed, S. H. Bigner, O. F. Ali, E. Dolan, O. M. Colvin, P. Houghton, G. Germain, J. T. Drummond, S. Keir, S. Marcelli, D. D. Bigner, & P. Modrich: Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res 57, 2933-6 (1997)
252. Anthoney, D. A., A. J. McIlwrath, W. M. Gallagher, A. R. M. Edlin, & R. Brown: Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res 56, 1374-1381 (1996)
253. Aebi, S., B. Kurdi-Haidar, R. Gordon, B. Cenni, H. Zheng, D. Fink, R. D. Christen, C. R. Boland, M. Koi, R. Fishel, & S. Howell: Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56, 3087-3090 (1996)
254. Fink, D., H. Zheng, S. Nebel, P. S. Norris, S. Aebi, T. P. Lin, A. Nehme, R. D. Christen, M. Haas, C. L. MacLeod, & S. B. Howell: In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res 57, 1841-5 (1997)
255. Wu, J., L. Gu, H. Wang, N. E. Geacintov, & G.-M. Li: Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis. Mol Cell Biol 19, 8292-8301 (1999)
256. Fritzell, J. A., L. Narayanan, S. M. Baker, C. E. Bronner, S. E. Andrew, T. A. Prolla, A. Bradley, F. R. Jirik, R. M. Liskay, & P. M. Glazer: Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res 57, 5143-7 (1997)
257. Huennekens, F. M.: The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul 34, 397-419 (1994)
258. Drummond, J. T., J. Genschel, E. Wolf, & P. Modrich: DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/ hMutSβratio and reduces the efficiency of base-base mismatch repair. Proc Natl Acad Sci U S A 94, 10144-9 (1997)
259. Marra, G., I. Iaccarino, T. Lettieri, G. Roscilli, P. Delmastro, & J. Jiricny: Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc Natl Acad Sci U S A 95, 8568-73 (1998)
260. Curt, G. A., D. N. Carney, K. H. Cowan, J. Jolivet, B. D. Bailey, J. C. Drake, K. S. Chien Song, J. D. Minna, & B. A. Chabner: Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. N Engl J Med 308, 199-202 (1983)
261. Schimke, R. T.: Methotrexate resistance and gene amplification. Mechanisms and implications. Cancer 57, 1912-7 (1986)
262. Schimke, R. T., R. J. Kaufman, F. W. Alt, & R. F. Kellems: Gene amplification and drug resistance in cultured murine cells. Science 202, 1051-5 (1978)
263. Linton, J. P., J. Y. Yen, E. Selby, Z. Chen, J. M. Chinsky, K. Liu, R. E. Kellems, & G. F. Crouse: Dual bidirectional promoters at the mouse dhfr locus: cloning and characterization of two mRNA classes of the divergently transcribed Rep-1 gene. Mol Cell Biol 9, 3058-72 (1989)
264. Fujii, H. & T. Shimada: Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J Biol Chem 264, 10057-10064 (1989)
265. Brown, K. D., A. Rathi, R. Kamath, D. I. Beardsley, Q. Zhan, J. L. Mannino, & R. Baskaran: The mismatch repair system is required for S-phase checkpoint activation. Nat Genet 33, 80-4 (2003)
266. Toft, N. J., D. J. Winton, J. Kelly, L. A. Howard, M. Dekker, H. te Riele, M. J. Arends, A. H. Wyllie, G. P. Margison, & A. R. Clarke: Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc Natl Acad Sci U S A 96, 3911-5 (1999)
267. Hickman, M. J. & L. D. Samson: Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A 96, 10764-9 (1999)
268. Degtyareva, N. P., P. Greenwell, E. R. Hofmann, M. O. Hengartner, L. Zhang, J. G. Culotti, & T. D. Petes: Caenorhabditis elegans DNA mismatch repair gene msh-2 is required for microsatellite stability and maintenance of genome integrity. Proc Natl Acad Sci U S A 99, 2158-63 (2002)
269. Duckett, D. R., S. M. Bronstein, Y. Taya, & P. Modrich: hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage. Proc Natl Acad Sci U S A 96, 12384-12388 (1999)
270. Gong, J. G., A. Costanzo, H. Q. Yang, G. Melino, W. G. Kaelin, Jr., M. Levrero, & J. Y. Wang: The tyrosine kinase c-Ab1 regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399, 806-9 (1999)
271. Shimodaira, H., A. Yoshioka-Yamashita, R. D. Kolodner, & J. Y. Wang: Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci U S A 100, 2420-5 (2003)
272. 4- methylthymine, or the cisplatin-d(GpG) adduct. Proc Natl Acad Sci U S A 93, 6443-6447 (1996)
273. Mello, J. A., S. Acharya, R. Fishel, & J. M. Essigmann: The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chemistry & Biology 3, 579-589 (1996)
274. Mu, D., M. Tursun, D. R. Duckett, J. T. Drummond, P. Modrich, & A. Sancar: Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol Cell Biol 17, 760-9 (1997)
275. Berardini, M., A. Mazurek, & R. Fishel: The effect of O6-methylguanine DNA adducts on the adenosine nucleotide switch functions of hMSH2-hMSH6 and hMSH2-hMSH3. J Biol Chem 275, 27851-7 (2000)
276. Li, G.-M., H. Wang, & L. J. Romano: Human MutSα specifically binds to DNA containing aminofluorene and acetylaminofluorene adducts. J Biol Chem 271, 24084-24088 (1996)
277. Ni, T. T., G. T. Marsischky, & R. D. Kolodner: MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol Cell 4, 439-44 (1999)
278. Mazurek, A., M. Berardini, & R. Fishel: Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem 277, 8260-6 (2002)
279. Wang, H., C. W. Lawrence, G. M. Li, & J. B. Hays: Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J Biol Chem 274, 16894-900 (1999)
280. Fishel, R.: The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Res 61, 7369-74 (2001)
281. Ben-Yehuda, D., S. Krichevsky, O. Caspi, D. Rund, A. Polliack, D. Abeliovich, O. Zelig, V. Yahalom, O. Paltiel, R. Or, T. Peretz, S. Ben-Neriah, O. Yehuda, & E. A. Rachmilewitz: Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 88, 4296-303 (1996)
282. de Wind, N., M. Dekker, v. A., M. van der Valk, & H. te Riele: Mouse model for hereditary nonpolyposis colorectal cancer. Cancer Res 58, 248-255 (1998)